Dr. Moncef Slaoui is a Partner at Medicxi Ventures (Jersey) Ltd., a Chairman at Vaxcyte, Inc. and a Chairman at Galvani Bioelectronics Ltd.
He is on the Board of Directors at ModernaTX, Inc., Artizan Biosciences, Inc. and Biotechnology Innovation Organization. Dr. Slaoui was previously employed as an Independent Director by Lonza Group AG, an Independent Non-Executive Director by Moderna, Inc., a Director, Chairman-Research & Development by Genelabs Technologies, Inc., an Executive Director & Chairman-Global Vaccines by GlaxoSmithKline Plc, a Director & Strategic Advisor by Longwood Fund Management LLC, a Professor by Université de Mons, and a Professor by University of Mons Hainaut.
He also served on the board at Intellia Therapeutics, Inc., PhRMA Foundation, Agency for Science, Technology & Research, International AIDS Vaccine Initiative, Inc. and Pharmaceutical Research & Manufacturers of America.
He received his graduate degree from Tufts University, a graduate degree from Harvard Medical School and a doctorate degree from Université Libre de Bruxelles.